JP2014513051A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014513051A5 JP2014513051A5 JP2013554528A JP2013554528A JP2014513051A5 JP 2014513051 A5 JP2014513051 A5 JP 2014513051A5 JP 2013554528 A JP2013554528 A JP 2013554528A JP 2013554528 A JP2013554528 A JP 2013554528A JP 2014513051 A5 JP2014513051 A5 JP 2014513051A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- unsubstituted
- substituted
- hydrogen
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161442400P | 2011-02-14 | 2011-02-14 | |
| US61/442,400 | 2011-02-14 | ||
| PCT/US2012/024881 WO2012112451A1 (en) | 2011-02-14 | 2012-02-13 | Ester derivatives of bimatoprost compositions and methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014513051A JP2014513051A (ja) | 2014-05-29 |
| JP2014513051A5 true JP2014513051A5 (enExample) | 2015-04-02 |
| JP5885271B2 JP5885271B2 (ja) | 2016-03-15 |
Family
ID=45755562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013554528A Expired - Fee Related JP5885271B2 (ja) | 2011-02-14 | 2012-02-13 | ビマトプロストのエステル誘導体の組成物および方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20130324606A1 (enExample) |
| EP (1) | EP2675786B1 (enExample) |
| JP (1) | JP5885271B2 (enExample) |
| KR (1) | KR101935068B1 (enExample) |
| CN (1) | CN103459368B (enExample) |
| AR (1) | AR088774A1 (enExample) |
| AU (1) | AU2012217922B2 (enExample) |
| BR (1) | BR112013020719B1 (enExample) |
| CA (1) | CA2827446C (enExample) |
| RU (1) | RU2599249C2 (enExample) |
| TW (1) | TWI642653B (enExample) |
| WO (1) | WO2012112451A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007111806A2 (en) * | 2006-03-23 | 2007-10-04 | Massachusetts Eye And Ear Infirmary | Cyclopentane heptanoic acid compounds for reducing body fat |
| KR20180021919A (ko) | 2009-11-09 | 2018-03-05 | 알러간, 인코포레이티드 | 모발 성장을 촉진하기 위한 조성물 및 방법 |
| US9149484B2 (en) | 2009-11-09 | 2015-10-06 | Allergan, Inc. | Compositions and methods for stimulating hair growth |
| WO2012099942A2 (en) | 2011-01-19 | 2012-07-26 | Terakine Therapeutics, Inc. | Methods and compositions for treating metabolic syndrome |
| US8859616B2 (en) * | 2011-01-21 | 2014-10-14 | Allergan, Inc. | Compounds and methods for enhancing hair growth |
| US8426471B1 (en) | 2011-12-19 | 2013-04-23 | Topokine Therapeutics, Inc. | Methods and compositions for reducing body fat and adipocytes |
| AU2013338043A1 (en) * | 2012-10-29 | 2015-05-21 | Allergan, Inc. | Phosphate esters of bimatoprost and the prostamides |
| JP5877620B2 (ja) | 2012-11-21 | 2016-03-08 | トポカイン セラピューティックス， インコーポレイテッド | 体脂肪を局所的に増大させるための方法および組成物 |
| EP2968093A1 (en) * | 2013-03-14 | 2016-01-20 | Allergan, Inc. | Topical compositions comprising bimatoprost and methods for stimulating hair growth therewith |
| NO2753788T3 (enExample) | 2013-05-10 | 2018-06-16 | ||
| WO2014186504A1 (en) | 2013-05-15 | 2014-11-20 | Topokine Therapeutics, Inc. | Methods and compositions for topical delivery of prostaglandins to subcutaneous fat |
| WO2015200425A1 (en) | 2014-06-27 | 2015-12-30 | Topokine Therapeutics, Inc. | Topical dosage regimen |
| US11478437B2 (en) | 2016-07-05 | 2022-10-25 | Jenivision Inc. | Formulations for hair growth |
| JP7141025B1 (ja) * | 2021-11-11 | 2022-09-22 | エルデシエロ プライベート リミテッド | 化合物、組成物、方法、及び製造方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| EP0495421B1 (en) | 1991-01-15 | 1996-08-21 | Alcon Laboratories, Inc. | Use of carrageenans in topical ophthalmic compositions |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| US5352708A (en) | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| US5688819A (en) | 1992-09-21 | 1997-11-18 | Allergan | Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| US5972991A (en) | 1992-09-21 | 1999-10-26 | Allergan | Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US5574066A (en) * | 1992-10-28 | 1996-11-12 | Allergan | Intraocular pressure reducing 15-acyl prostaglandins |
| JP2818381B2 (ja) * | 1994-01-18 | 1998-10-30 | 帝人株式会社 | ７−チアプロスタグランジン類およびその製造法 |
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| JPH10259179A (ja) * | 1996-09-19 | 1998-09-29 | Santen Pharmaceut Co Ltd | 多置換アリールオキシ基を有するプロスタグランジン類およびその用途 |
| US6395787B1 (en) * | 2000-02-08 | 2002-05-28 | Allergan Sales, Inc. | Ocular hypotensive lipids |
| US7351404B2 (en) | 2002-02-04 | 2008-04-01 | Allergan, Inc. | Method of enhancing hair growth |
| WO2007037849A2 (en) | 2005-09-16 | 2007-04-05 | Allergan, Inc. | Compositions and methods for the intraocular transport of therapeutic agents |
| US8252771B2 (en) * | 2007-01-31 | 2012-08-28 | Allergan, Inc. | Biomaterials and a method for making and using same |
| US7638557B2 (en) * | 2007-10-31 | 2009-12-29 | Meta Cosmetics, Llc | Prostaglandin analog compositions to treat epithelial-related conditions |
| AR076731A1 (es) * | 2008-05-09 | 2011-07-06 | Pfizer | Prostamidas donadoras de oxido nitrico, uso de los mismos y composiciones farmaceuticas |
| KR20180021919A (ko) | 2009-11-09 | 2018-03-05 | 알러간, 인코포레이티드 | 모발 성장을 촉진하기 위한 조성물 및 방법 |
-
2012
- 2012-02-13 EP EP12705582.0A patent/EP2675786B1/en not_active Not-in-force
- 2012-02-13 AU AU2012217922A patent/AU2012217922B2/en not_active Ceased
- 2012-02-13 US US13/985,263 patent/US20130324606A1/en not_active Abandoned
- 2012-02-13 KR KR1020137024231A patent/KR101935068B1/ko not_active Expired - Fee Related
- 2012-02-13 CA CA2827446A patent/CA2827446C/en active Active
- 2012-02-13 RU RU2013141849/04A patent/RU2599249C2/ru active
- 2012-02-13 JP JP2013554528A patent/JP5885271B2/ja not_active Expired - Fee Related
- 2012-02-13 CN CN201280014860.XA patent/CN103459368B/zh not_active Expired - Fee Related
- 2012-02-13 BR BR112013020719-1A patent/BR112013020719B1/pt not_active IP Right Cessation
- 2012-02-13 US US13/371,851 patent/US8865766B2/en active Active
- 2012-02-13 WO PCT/US2012/024881 patent/WO2012112451A1/en not_active Ceased
- 2012-02-14 AR ARP120100482A patent/AR088774A1/es not_active Application Discontinuation
- 2012-02-14 TW TW101104790A patent/TWI642653B/zh not_active IP Right Cessation
-
2014
- 2014-09-16 US US14/488,093 patent/US9499478B2/en not_active Expired - Fee Related